These courses are intended for internal hospital staff.

Activity Description:

This is a virtual CME-certified educational intervention designed to address the identified gaps related to potentially compromising conditions of the respiratory and cardiovascular systems. The online format will allow for convenient access and thus reach a broad audience of medical professionals. Deep vein thrombosis and or pulmonary embolism can strike people at any age, including those with an otherwise baseline health status. Vague symptomology often masks these potentially serious conditions, making it paramount pre-hospital providers know how to assess and manage these patients. This CME will review the risk factors and decision making process EMS should consider when encountering a patient suspicious for either condition and discuss new interventional treatments available to patients diagnosed with these conditions.

Target Audience: 

Physicians, Nurse Practitioners, Physician Assistance, Residents, Medical Students, Emergency Medical Services

Learning Objectives:

• Recognize the risk factors for deep vein thrombosis and pulmonary embolism.
• Describe the processes of clinical decision making for acute treatment for pulmonary embolism.
• Discuss new interventional treatment for high-risk pulmonary embolism.

Moderator:

Presenter - Ehrin J. Armstrong, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.